Pharmaceuticals in the environment: Biodegradation and effects on natural microbial communities. A review

Journal of Pharmaceutical and Biomedical Analysis

Volumn 106, Issue , 2015, Pages 25-36

  Barra Caracciolo, Anna ^a   Topp, Edward ^b   Grenni, Paola ^a  

^a WATER RESEARCH INSTITUTE   (Italy)

^b AGRICULTURE AND AGRI FOOD CANADA   (Canada)

Author keywords

Analgesics; Antidepressants; Antiepileptics; Blood lipid regulators; Microbicides

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIINFECTIVE AGENT; ANTIPYRETIC AGENT; DISINFECTANT AGENT; HYPOCHOLESTEROLEMIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; DRUG;

BIOGEOCHEMICAL CYCLING; BJERKANDERA; CYTOPHAGA; DRUG INDUSTRY; FIRMICUTES; GAMMAPROTEOBACTERIA; LIPOPHILICITY; MICROBIAL ACTIVITY; MICROBIAL COMMUNITY; MICROBIAL DEGRADATION; MICROCOSM; PHANEROCHAETE; PRIORITY JOURNAL; REVIEW; SOLUBILITY; STENOTROPHOMONAS MALTOPHILIA; TRAMETES VERSICOLOR; VAPOR PRESSURE; WASTE WATER TREATMENT PLANT; ANALYSIS; ANIMAL; BIOREMEDIATION; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; HUMAN; METABOLISM; MICROBIOLOGY; POLLUTION; PROCEDURES;

ANIMALS; BIODEGRADATION, ENVIRONMENTAL; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MICROBIOLOGY; ENVIRONMENTAL MONITORING; ENVIRONMENTAL POLLUTION; HUMANS; PHARMACEUTICAL PREPARATIONS;

EID: 84923381210     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2014.11.040     Document Type: Review

References (153)

1. Monteiro S.C., Boxall A.B.A. Occurrence and fate of human pharmaceuticals in the environment. Rev. Environ. Contam. Toxicol. 2010, 202:53-154.
2. EMA, European Medicine Agency Recommendation on Pharmacovigilance Surveillance and Signal Detection of Veterinary Medicinal Products. Committee for Medicinal Products for Veterinary Use. MA/CVMP/PhVWP/901279/2011 2013, http://www.ema.europa.eu (accessed July 2014).
3. Zuccato E., Castiglioni S., Bagnati R., Melis M., Fanelli R. Source, occurrence and fate of antibiotics in the Italian aquatic environment. J. Hazard. Mater. 2010, 179:1042-1048.
4. Cardoso O., Porcher J.M., Sanchez W. Factory-discharged pharmaceuticals could be a relevant source of aquatic environment contamination: review of evidence and need for knowledge. Chemosphere 2014, 115:20-30.
5. Boxall A.B.A. The environmental side effects of medication - how are human and veterinary medicines in soils and water bodies affecting human and environmental health?. EMBO Rep. 2004, 5:1110-1116.
6. Zuccato E., Castiglioni S., Fanelli R. Identification of the pharmaceuticals for human use contaminating the Italian aquatic environment. J. Hazard. Mater. 2005, 122:205-209.
7. Ottmar K.J., Colosi L.M., Smith J.A. Development and application of a model to estimate wastewater treatment plant prescription pharmaceutical influent loadings and concentrations. Bull. Environ. Contam. Toxicol. 2010, 84:507-512.
8. Bottoni P., Caroli S., Barra Caracciolo A. Pharmaceuticals as priority water contaminants. Toxicol. Environ. Chem. 2010, 92:549-565.
9. Emke E., Evans S., Kasprzyk-Hordern B., de Voogt P. Enantiomer profiling of high loads of amphetamine and MDMA in communal sewage: a Dutch perspective. Sci. Total Environ. 2014, 487:666-672.
10. Muñoz I., Martínez Bueno M.J., Agüera A., Fernández-Alba A.R. Environmental and human health risk assessment of organic micro-pollutants occurring in a Spanish marine fish farm. Environ. Pollut. 2010, 158:1809-1816.
11. Jiang J.Q., Zhou Z. Removal of pharmaceutical residues by ferrate (VI). PLOS ONE 2013, 8:e55729.
12. Brozinski J.M., Lahti M., Meierjohann A., Oikari A., Kronberg L. The anti-inflammatory drugs diclofenac, naproxen and ibuprofen are found in the bile of wild fish caught downstream of a wastewater treatment plant. Environ. Sci. Technol. 2013, 47:342-348.
13. Radke M., Ulrich H., Wurm C., Kunkel U. Dynamics and attenuation of acidic pharmaceuticals along a river stretch. Environ. Sci. Technol. 2010, 44:2968-2974.
14. Daz-Cruz M.S., López De Alda M.J., Barceló D. Environmental behavior and analysis of veterinary and human drugs in soils, sediments and sludge. Trends Anal. Chem. 2003, 22:340-351.
15. Topp E., Hendel J.G., Lapen D.R., Chapman R. Fate of the nonsteroidal anti-inflammatory drug naproxen in agricultural soil receiving liquid municipal biosolids. Environ. Toxicol. Chem. 2008, 27:2005-2010.
16. Gottschall N., Topp E., Metcalfe C., Edwards M., Payne M., Kleywegt S., Russell P., Lapen D.R. Pharmaceutical and personal care products in groundwater, subsurface drainage, soil, and wheat grain, following a high single application of municipal biosolids to a field. Chemosphere 2012, 87:194-203.
17. Gottschall N., Topp E., Edwards M., Payne M., Kleywegt S., Russell P., Lapen D.R. Hormones, sterols, and fecal indicator bacteria in groundwater, soil, and subsurface drainage following a high single application of municipal biosolids to a field. Chemosphere 2013, 91:275-286.
18. Dolliver H., Gupta S. Antibiotic losses in leaching and surface runoff from manure-amended agricultural land. J. Environ. Qual. 2008, 37:1245-1253.
19. Sabourin L., Beck A., Duenk P.W., Kleywegt S., Lapen D.R., Li H., Metcalfe C.D., Payne M., Topp E. Runoff of pharmaceuticals and personal care products following application of dewatered municipal biosolids to an agricultural field. Sci. Total Environ. 2009, 407:4596-4604.
20. Lapworth D.J., Baran N., Stuart M.E., Ward R.S. Emerging organic contaminants in groundwater: a review of sources, fate and occurrence. Environ. Poll. 2012, 163:287-303.
21. Roberts P., Thomas K.V. The occurrence of selected pharmaceuticals in wastewater effluent and surface waters of the Tyne Estuary, UK and its tributaries. Sci. Total Environ. 2006, 356:143-153.
22. Thomas K.V., Hilton M.J. The occurrence of selected human pharmaceutical compounds in UK estuaries. Mar. Pollut. Bull. 2004, 49:436-444.
23. Thomas K.V., Langford K.H. Occurrence of pharmaceuticals in the aqueous environment. Analysis, Fate and Removal of Pharmaceuticals in the Water Cycle 2007, 341-363. Amsterdam. M. Barcelò, D. Petrovic (Eds.).
24. McEneff G., Barron L., Kelleher B., Paull B., Quinn B. A year-long study of the spatial occurrence and relative distribution of pharmaceutical residues in sewage effluent, receiving marine waters and marine bivalves. Sci. Total Environ. 2014, 476-477:317-326.
25. Grenni P., Patrolecco L., Ademollo N., Tolomei A., Barra Caracciolo A. Degradation of gemfibrozil and naproxen in a river water ecosystem. Microchem. J. 2013, 107:158-164.
26. Patrolecco L., Ademollo N., Grenni P., Tolomei A., Barra Caracciolo A., Capri S. Simultaneous determination of human pharmaceuticals in water samples by solid phase extraction and HPLC with UV-Fluorescence detection. Microchem. J. 2013, 107:165-171.
27. Carvalho R.N., Arukwe A., Ait-Aissa S., Bado-Nilles A., Balzamo S., Baun A., Belkin S., Blaha L., Brion F., Conti D., Creusot N., Essig Y., Ferrero V.E., Flander-Putrle V., Fürhacker M., Grillari-Voglauer R., Hogstrand C., Jonáš A., Kharlyngdoh J.B., Kharlyngdoh J.B., Loos R., Lundebye A.K., Modig C., Olsson P.E., Pillai S., Polak N., Potalivo M., Sanchez W., Schifferli A., Schirmer K., Sforzini S., Stürzenbaum S.R., Søfteland L., Turk V., Viarengo A., Werner I., Yagur-Kroll S., Zounková R., Lettieri T. Mixtures of chemical pollutants at European legislation safety concentrations: how safe are they?. Toxicol. Sci. 2014, 141:218-233.
28. Topp E., Chapman R., Devers-Lamrani M., Hartmann A., Marti R., Martin-Laurent F., Sabourin L., Scott A., Sumarah M. Accelerated biodegradation of veterinary antibiotics in agricultural soil following long-term exposure, and isolation of a sulfamethazine-degrading sp. J. Environ. Qual. 2013, 42:173-178.
29. Macherius A., Lapen D.R., Reemtsma T., Römbke J., Topp E., Coors A. Triclocarban, triclosan and its transformation product methyl triclosan in native earthworm species four years after a commercial-scale biosolids application. Sci. Total Environ. 2014, 472:235-238.
30. Santos J., Aparicio I., Callejón M., Alonso E. Occurrence of pharmaceutically active compounds during 1-year period in wastewaters from four wastewater treatment plants in Seville (Spain). J. Hazard. Mater. 2009, 164:1509-1516.
31. Hampel M., Alonso E., Aparicio I., Bron J.E., Santos J.L., Taggart J.B., Leaver M.J. Potential physiological effects of pharmaceutical compounds in Atlantic salmon (Salmo salar) implied by transcriptomic analysis. Environ. Sci. Pollut. Res. Int. 2010, 17:917-933.
32. Mimeault C., Woodhouse A.J., Miao X.S., Metcalfe C.D., Moon T.W., Trudeau V.L. The human lipid regulator, gemfibrozil bioconcentrates and reduces testosterone in the goldfish, Carassius auratus. Aquat. Toxicol. 2005, 73:44-54.
33. Franzellitti S., Buratti S., Valbonesi P., Fabbri E. The mode of action (MOA) approach reveals interactive effects of environmental pharmaceuticals on Mytilus galloprovincialis. Aquat. Toxicol. 2013, 140-141:249-256.
34. Pomati F., Castiglioni S., Zuccato E., Fanelli R., Vigetti D., Rossetti C., Calamari D. Effects of a complex mixture of therapeutic drugs at environmental levels on human embryonic cells. Environ. Sci. Technol. 2006, 40:2442-2447.
35. Marti R., Scott A., Tien Y.C., Murray R., Sabourin L., Zhang Y., Topp E. Impact of manure fertilization on the abundance of antibiotic-resistant bacteria and frequency of detection of antibiotic resistance genes in soil and on vegetables at harvest. Appl. Environ. Microbiol. 2013, 79:5701-5709.
36. Andersson D.I., Hughes D. Microbiological effects of sublethal levels of antibiotics. Nat. Rev. Microbiol. 2014, 12:465-478.
37. Wharfe E.S., Winder C.L., Jarvis R.M., Goodacre R. Monitoring the effects of chiral pharmaceuticals on aquatic microorganisms by metabolic fingerprinting. Appl. Environ. Microbiol. 2010, 76:2075-2085.
38. Alvarino T., Katsou E., Malamis S., Suarez S., Omil F., Fatone F. Inhibition of biomass activity in the via nitrite nitrogen removal processes by veterinary pharmaceuticals. Bioresour. Technol. 2014, 152:477-483.
39. Gros M., Petrović M., Barceló D. Wastewater treatment plants as a pathway for aquatic contamination by pharmaceuticals in the Ebro River basin (Northeast Spain). Environ. Toxicol. Chem. 2007, 26:1553-1562.
40. Onesios K.M., Yu J.T., Bouwer E.J. Biodegradation and removal of pharmaceuticals and personal care products in treatment systems: a review. Biodegradation 2009, 20:441-466.
41. Megharaj M., Ramakrishnan B., Venkateswarlu K., Sethunathan N., Naidu R. Bioremediation approaches for organic pollutants: a critical perspective. Environ. Int. 2011, 37:1362-1375.
42. Reed H.E., Martiny J.B.H. Testing the functional significance of microbial composition in natural communities. FEMS Microbiol. Ecol. 2007, 62:161-170.
43. Rodarte-Morales A.I., Feijoo G., Moreira M.T., Lema J.M. Biotransformation of three pharmaceutical active compounds by the fungus Phanerochaete chrysosporium in a fed batch stirred reactor under air and oxygen supply. Biodegradation 2011, 23:145-156.
44. Lahti M., Oikari A. Microbial transformation of pharmaceuticals Naproxen, bisoprolol, and diclofenac in aerobic and anaerobic environments. Arch. Environ. Contam. Toxicol. 2011, 61:202-210.
45. de Groot R.S., Wilson M.A., Boumans R.M.J. A typology for the classification, description and valuation of ecosystem functions, goods, services. Ecol. Econ. 2002, 41:393-408.
46. Gerbersdorf S.U., Hollert H., Brinkmann M., Wieprecht S., Schuttrumpf H., Manz W. Anthropogenic pollutants affect ecosystem services of freshwater sediments: the need for a triad plus×approach. J. Soils Sedim. 2011, 11:1099-1114.
47. Luo Y., Guo W., Ngo H.H., Nghiem L.D., Hai F.I., Zhang J., Liang S., Wang X.C. A review on the occurrence of micropollutants in the aquatic environment and their fate and removal during wastewater treatment. Sci. Total Environ. 2014, 473-474:619-641.
48. Venkatesan A.K., Pycke B.F., Barber L.B., Lee K.E., Halden R.U. Occurrence of triclosan, triclocarban, and its lesser chlorinated congeners in Minnesota freshwater sediments collected near wastewater treatment plants. J. Hazard. Mater. 2012, 229-230:29-35.
49. Bueno M.J., Gomez M.J., Herrera S., Hernando M.D., Agüera A., Fernández-Alba A.R. Occurrence and persistence of organic emerging contaminants and priority pollutants in five sewage treatment plants of Spain: two years pilot survey monitoring. Environ. Pollut. 2012, 164:267-273.
50. Gavrilescu M., Demnerová K., Aamand J., Agathos S., Fava F. Emerging pollutants in the environment: present and future challenges in biomonitoring, ecological risks and bioremediation. N. Biotechnol. 2015, 32:147-156.
51. Vane J.R., Botting R.M. Mechanism of action of anti-inflammatory drugs. Int. J. Tissue React. 1998, 20:3-15.
52. Loos R., Gawlik B.M., Locoro G., Rimaviciute E., Contini S., Bidoglio G. EU Wide Monitoring Survey of Polar Persistent Pollutants in European River Waters 2008, European Commission, Joint Research Centre, Institute for Environment and Sustainability, http://bookshop.europa.eu/it/eu-wide-monitoring-survey-of-polar-persistent-pollutants-in-european-river-waters-pbLBNA23568.
53. Tixier C., Singer H.P., Oellers J., Müller S.R. Occurrence and fate of carbamazepine, clofibric acid, diclofenac, ibuprofen, ketoprofen, and naproxen in surface waters. Environ. Sci. Technol. 2003, 37:1061-1068.
54. Rabiet M., Togola A., Brissaud F., Seidel J.L., Budzinski H., Elbaz-Poulichet F. Consequences of treated water recycling as regards pharmaceuticals and drugs in surface and ground waters of a medium-sized Mediterranean catchment. Environ. Sci. Technol. 2006, 40:5282-5288.
55. Araujo L., Villa N., Camargo N., Bustos M., Garcìa T. Persistence of gemfibrozil, naproxen and mefenamic acid in natural waters. Environ. Chem. Lett. 2011, 9:13-18.
56. Isidori M., Lavorgna M., Nardelli A., Parrella A., Previtera L., Rubino M. Ecotoxicity of naproxen and its phototransformation products. Sci. Total Environ. 2005, 348:93-101.
57. Grenni P., Patrolecco L., Ademollo N., Di Lenola M., Barra Caracciolo A. Capability of the natural microbial community in a river water ecosystem to degrade the drug Naproxen. Environ. Sci. Poll. Res. 2014, 23:13470-13479.
58. Wojcieszyńska D., Domaradzka D., Hupert-Kocurek K., Guzik U. Bacterial degradation of naproxen - undisclosed pollutant in the environment. J. Environ. Manag. 2014, 145:157-161.
59. Lin K., Gan J. Sorption and degradation of wastewater-associated non-steroidal anti-inflammatory drugs and antibiotics in soils. Chemosphere 2011, 83:240-246.
60. Grossberger A., Hadar Y., Borch T., Chefetz B. Biodegradability of pharmaceutical compounds in agricultural soils irrigated with treated wastewater. Environ. Pollut. 2014, 185:168-177.
61. Cruz-Morató C., Ferrando-Climent L., Rodriguez-Mozaz S., Barceló D., Marco-Urrea E., Vicent T., Sarrà M. Degradation of pharmaceuticals in non-sterile urban wastewater by Trametes versicolor in a fluidized bed bioreactor. Water Res. 2013, 47:5200-5210.
62. Marco-Urrea E., Pérez-Trujillo M., Vicent T., Caminal G. Ability of white-rot fungi to remove selected pharmaceuticals and identification of degradation products of ibuprofen by Trametes versicolor. Chemosphere 2009, 74:765-772.
63. Schweitzer B., Huber I., Amann R., Ludwig W., Simon M. α- and β-Proteobacteria control the consumption and release of amino acids on lake snow aggregates. Appl. Environ. Microb. 2001, 67:632-645.
64. Wang S., Gunsch C.K. Effects of selected pharmaceutically active compounds on the ammonia oxidizing bacterium Nitrosomonas europea. Chemosphere 2011, 82:565-572.
65. Wong C.S. Environmental fate processes and biochemical transformations of chiral emerging organic pollutants. Anal. Bioanal. Chem. 2006, 386:544-558.
66. Winkler M., Lawrence J.R., Neu T.R. Selective degradation of ibuprofen and clofibric acid in two model river biofilm systems. Water Res. 2001, 35:3197-3205.
67. Lin A.Y., Plumlee M.H., Reinhard M. Natural attenuation of pharmaceuticals and alkylphenol polyethoxylate metabolites during river transport: photochemical and biological transformation. Environ. Toxicol. Chem. 2006, 25:1458-1464.
68. Carr D.L., Morse A.N., Zak J.C., Anderson T.A. Biological degradation of common pharmaceuticals and personal care products in soils with high water content. Water Air Soil Pollut. 2011, 217:127-134.
69. Chen Y., Rosazza J.P.N. Microbial transformation of ibuprofen by a Nocardia species. Appl. Environ. Microbiol. 1994, 60:1292-1296.
70. Murdoch R.V., Hay A.G. Formation of catechols via removal of acid side chains from ibuprofen and related aromatic acids. Appl. Environ. Microbiol. 2005, 71:6121-6125.
71. Quintana J.B., Weiss S., Reemtsma T. Pathways and metabolites of microbial degradation of selected acidic pharmaceutical and their occurrence in municipal wastewater treated by a membrane bioreactor. Water Res. 2005, 39:2654-2664.
72. Ferrando-Climent L., Collado N., Buttiglieri G., Gros M., Rodriguez-Roda I., Rodriguez-Mozaz S., Barceló D. Comprehensive study of ibuprofen and its metabolites in activated sludge batch experiments and aquatic environment. Sci. Total Environ. 2012, 438:404-413.
73. Elvers K.T., Wright S.J. Antibacterial activity of the anti-inflammatory compound ibuprofen. Lett. Appl. Microbiol. 1995, 20:82-84.
74. Sanyal A.K., Roy D., Chowdhury B., Banerjee A.B. Ibuprofen, a unique anti-inflammatory compound with antifungal activity against dermatophytes. Lett. Appl. Microbiol. 1993, 17:109-111.
75. Lawrence J.R., Swerhone G.D.W., Wassenaar L.I., Neu T.R. Effects of selected pharmaceuticals on riverine biofilm communities. Can. J. Microbiol. 2005, 51:655-669.
76. Veach A., Bernot M.J., Mitchell J.K. The influence of six pharmaceuticals on freshwater sediment microbial growth incubated at different temperatures and UV exposures. Biodegradation 2012, 23:497-507.
77. Corcoll N., Acuña V., Barceló D., Casellas M., Guasch H., Huerta B., Petrovic M., Ponsatí L., Rodríguez-Mozaz S., Sabater S. Pollution-induced community tolerance to non-steroidal anti-inflammatory drugs (NSAIDs) in fluvial biofilm communities affected by WWTP effluents. Chemosphere 2014, 112:185-193.
78. Girardi C., Nowak K.M., Carranza-Diaz O., Lewkow B., Miltner A., Gehre M., Schäffer A., Kästner M. Microbial degradation of the pharmaceutical ibuprofen and the herbicide 2,4-D in water and soil - use and limits of data obtained from aqueous systems for predicting their fate in soil. Sci. Total Environ. 2013, 444:32-42.
79. Stuer-Lauridsen F., Birkved M., Hansen L.P., Holten Lützhøft H.C., Halling-Sørensen B. Environmental risk assessment of human pharmaceuticals in Denmark after normal therapeutic use. Chemosphere 2000, 40:783-793.
80. Han S., Choi K., Kim J., Ji K., Kim S., Ahn B., Yun J., Choi K., Khim J.S., Zhang X., Giesy J.P. Endocrine disruption and consequences of chronic exposure to ibuprofen in Japanese medaka (Oryzias latipes) and freshwater Cladocerans Daphnia magna and Moina macrocopa. Aquat. Toxicol. 2010, 98:256-264.
81. Parolini M., Binelli A., Provini A. Chronic effects induced by ibuprofen on the freshwater bivalve Dreissena polymorpha. Ecotoxicol. Environ. Saf. 2011, 74:1586-1594.
82. European Commission (EC) Report from the Commission to the European parliament and the Council on the outcome of the review of Annex X to Directive 2000/60/EC of the European Parliament and of the Council on priority substances in the field of water policy 2012, COM(2011) 875 final http://www.parliament.bg/pub/ECD/114884COM_2011_875_EN_ACTE_f.pdf (accessed November 2014).
83. Al-Rajab A.J., Sabourin L., Lapen D.R., Topp E. The non-steroidal anti-inflammatory drug diclofenac is readily biodegradable in agricultural soils. Sci. Total Environ. 2010, 409:78-82.
84. David L.S., Frederick W., Tom W.J.H. Rheumatoid arthritis. Lancet 2010, 376:1094-1108.
85. Ferreira A.P. Trace analysis of pharmaceutical residues in wastewater treatment plants in Rio de Janeiro, Brazil. J. Chem. Health Risks 2014, 4:1-12.
86. Chen F., Ying G.G., Kong L.X., Wang L., Zhao J.L., Zhou L.J., Zhang L.J. Distribution and accumulation of endocrine-disrupting chemicals and pharmaceuticals in wastewater irrigated soils in Hebei, China. Environ. Pollut. 2011, 159:1490-1498.
87. Gröning J., Held C., Garten C., Claussnitzer U., Kaschabek S.R., Schlömann M. Transformation of diclofenac by the indigenous microflora of river sediments and identification of a major intermediate. Chemosphere 2007, 69:509-516.
88. Buser H.-R., Müller M.D., Theobald N. Occurrence of the pharmaceutical drug clofibric acid and the herbicide mecoprop in various Swiss lakes and in the North Sea. Environ. Sci. Technol. 1998, 32:188-192.
89. 2 and ozone. Water Res. 2004, 38:414-422.
90. Green R.E., Newton I., Shultz S., Cunningham A.A., Gilbert M., Pain D.J., Prakash V. Diclofenac poisoning as a cause of vulture population declines across the Indian subcontinent. J. Appl. Ecol. 2004, 41:793-800.
91. Hussain I., Khan M.Z., Khan A., Javed I., Saleemi M.K. Toxicological effects of diclofenac in four avian species. Avian Pathol. 2008, 37:315-321.
92. Dastida S.G., Ganguly K., Chaudhuri K., Chakrabarty A.N. The anti-bacterial action of diclofenac shown by inhibition of DNA synthesis. Int. J. Antimicrob. Agents 2000, 14:249-251.
93. Paje M.L.F., Kuhlicke U., Winkler M., Neu T.R. Inhibition of lotic biofilms by diclofenac. Appl. Microbiol. Biotechnol. 2002, 59:488-494.
94. Lawrence J.R., Swerhone G.D.W., Topp E., Korber D.R., Neu T.R., Wassenaar L.I. Structural and functional responses of river biofilm communities to the nonsteroidal anti-inflammatory diclofenac. Environ. Toxicol. Chem. 2007, 26:573-582.
95. Khetan S.K., Collins T.J. Human pharmaceuticals in the aquatic environment: a challenge to Green Chemistry. Chem. Rev. 2007, 107:2319-2364.
96. Gracia-Lor E., Sancho J.V., Serrano R., Hernández F. Occurrence and removal of pharmaceuticals in wastewater treatment plants at the Spanish Mediterranean area of Valencia. Chemosphere 2012, 87:453-462.
97. Loos R., Gawlik B.M., Locoro G., Rimaviciute E., Contini S., Bidoglio G. EU-wide survey of polar organic persistent pollutants in European river waters. Environ. Pollut. 2009, 157:561-568.
98. Zimetbaum P., Frishman W.H., Kahn S. Effects of gemfibrozil and other fibric acid-derivatives on blood lipids and lipoproteins. J. Clin. Pharmacol. 1991, 31:25-37.
99. IARC, International Agency for Research on Cancer Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Overall Evaluation of Carcinogenicity: An Updating of IARC Monographs 60 1996, Lyon, France, 427 pp.
100. Lyssimachou A., Thibaut R., Gisbert E., Porte C. Gemfibrozil modulates cytochrome P450 and peroxisome proliferation-inducible enzymes in the liver of the yellow European eel (Anguilla anguilla). Environ. Sci. Pollut. Res. Int. 2014, 21:862-871.
101. Stumpf M., Ternes T.A., Wilken R.D., Rodrigues S.V., Baumann W. Polar drug residues in sewage and natural waters in the state of Rio de Janeiro, Brazil. Sci. Total Environ. 1999, 225:135-141.
102. Kang S.I., Kang S.Y., Kanaly R.A., Lee E., Lim Y., Hur H.G. Rapid oxidation of ring methyl groups is the primary mechanism of biotransformation of gemfibrozil by the fungus Cunninghamella elegans. Arch. Microbiol. 2009, 191:509-517.
103. Zhou N.A., Lutovsky A.C., Andaker G.L., Gough H.L., Ferguson J.F. Cultivation and characterization of bacterial isolates capable of degrading pharmaceutical and personal care products for improved removal in activated sludge wastewater treatment. Biodegradation 2013, 24:813-827.
104. Fang Y., Karnjanapiboonwong A., Chase D.A., Wang J., Morse A.N., Anderson T.A. Occurrence, fate, and persistence of gemfibrozil in water and soil. Environ. Toxicol. Chem. 2012, 31:550-555.
105. Santos L.H., Araújo A.N., Fachini A., Pena A., Delerue-Matos C., Montenegro M.C. Ecotoxicological aspects related to the presence of pharmaceuticals in the aquatic environment. J. Hazard. Mater. 2010, 175:45-95.
106. Salgado R., Oehmen A., Carvalho G., Noronha J.P., Reis M.A. Biodegradation of clofibric acid and identification of its metabolites. J. Hazard. Mater. 2012, 241-242:182-189.
107. Brooks B.W., Chambliss C.K., Stanley J.K., Ramirez A., Banks K.E., Johnson R.D., Lewis R.J. Determination of select antidepressants in fish from an effluent-dominated stream. Environ. Toxicol. Chem. 2005, 24:464-469.
108. Calisto V., Esteves V.I. Psychiatric pharmaceuticals in the environment. Chemosphere 2009, 77:1257-1274.
109. Fent K., Weston A.A., Caminada D. Review ecotoxicology of human pharmaceuticals. Aquat. Toxicol. 2006, 76:122-159.
110. Mennigen J.A., Martyniuk C.J., Crump K., Xiong H., Zhao E., Popesku J., Anisman H., Cossins A.R., Xia X., Trudeau V.L. Effects of fluoxetine on the reproductive axis of female goldfish (Carassius auratus). Physiol. Genomics 2008, 35:273-282.
111. Nödler K., Voutsa D., Licha T. Polar organic micropollutants in the coastal environment of different marine systems. Mar. Pollut. Bull. 2014, 85:50-59.
112. Benotti M.J., Brownawell B.J. Microbial degradation of pharmaceuticals in estuarine and coastal seawater. Environ. Pollut. 2009, 157:994-1002.
113. Scheytt T., Mersmann P., Lindstadt R., Heberer T. 1-Octanol/water partition coefficients of 5 pharmaceuticals from human medical care: carbamazepine, clofibric acid, diclofenac, ibuprofen, and propyphenazone. Water Air Soil Pollut. 2005, 165:3-11.
114. Williams C.F., McLain J.E. Soil persistence and fate of carbamazepine, lincomycin, caffeine, and ibuprofen from wastewater reuse. J. Environ. Qual. 2012, 41:1473-1480.
115. Nakada N., Kiri K., Shinohara H., Harada A., Kuroda K., Takizawa S., Takada H. Evaluation of pharmaceuticals and personal care products as water-soluble molecular markers of sewage. Environ. Sci. Technol. 2008, 42:6347-6353.
116. Tran N.H., Li J., Hu J., Ong S.L. Occurrence and suitability of pharmaceuticals and personal care products as molecular markers for raw wastewater contamination in surface water and groundwater. Environ. Sci. Pollut. Res. Int. 2014, 21:4727-4740.
117. Kinney C.A., Furlong E.T., Zaugg S.D., Burkhard M.R., Werner S.L., Cahill J.D., Jorgensen G.R. Survey of organic wastewater contaminants in biosolids destined for land application. Environ. Sci. Technol. 2006, 40:7207-7215.
118. Maeng S.K., Sharma S.K., Abel C.D.T., Magic-Knezev A., Amy G.L. Role of biodegradation in the removal of pharmaceutically active compounds with different bulk organic matter characteristics through managed aquifer recharge: batch and column studies. Water Res. 2011, 45:4722-4736.
119. Kang S.I., Kang S.Y., Hur H.G. Identification of fungal metabolites of anticonvulsant drug carbamazepine. Appl. Microbiol. Biotechnol. 2008, 79:663-669.
120. Gauthier H., Yargeau V., Cooper D.G. Biodegradation of pharmaceuticals by Rhodococcus rhodochrous and Aspergillus niger by co-metabolism. Sci. Total Environ. 2010, 408:1701-1706.
121. VITEK Antibiotic Classification and Modes of Action: Antibiotic Classification 2008, VITEK 2-Technology. ©bioMérieux, Inc., Customer Education, http://www.biomerieux-usa.com/upload/VITEK-Bus-Module-1-Antibiotic-Classificationand-Modes-of-Action-1.pdf (accessed November 2014).
122. Flynn W.T. The Judicious Use of Medically Important Antimicrobial Drugs in Food-Producing Animals 2012, Center for Veterinary Medicine (HFV-1), Food and Drug Administration, U.S. Department of Health and Human Services, http://www.fda.gov/AnimalVeterinary/SafetyHealth/AntimicrobialResistance/JudiciousUseofAntimicrobials/ (accessed November 2014).
123. Kümmerer K. Significance of antibiotics in the environment. J. Antimicrob. Chemother. 2003, 52:5-7.
124. Kümmerer K. Antibiotics in the aquatic environment - a review - Part I. Chemosphere 2009, 75:417-434.
125. European Union Communication from the Commission to the European Parliament and the Council, Action Plan Against the Rising Threats from Antimicrobial Resistance 2011, 748. COM, http://ec.europa.eu/health/antimicrobial_resistance/key_documents/index_en.htm (accessed November 2014).
126. Kreuzig R., Höltge S. Investigations on the fate of sulfadiazine in manured soil: laboratory experiments and test plot studies. Environ. Toxicol. Chem. 2005, 24:771-776.
127. Tenson T., Lovmar M., Ehrenberg M. The mechanism of action of macrolides, lincosamides and streptogramin B reveals the nascent peptide exit path in the ribosome. J. Mol. Biol. 2003, 25:1005-1014.
128. Pyörälä S., Baptiste K.E., Catry B., van Duijkeren E., Greko C., Moreno M.A., Pomba M.C., Rantala M., Ružauskas M., Sanders P., Threlfall E.J., Torren-Edo J., Törneke K. Macrolides and lincosamides in cattle and pigs: use and development of antimicrobial resistance. Vet. J. 2014, 200:230-239.
129. WHO Report of the 1st Meeting of the WHO Advisory Group on Integrated Surveillance of Antimicrobial Resistance (AGISAR) 2011, http://www.who.int/foodborne_disease/resistance/agisar_June09/en/ (accessed November 2014).
130. EMA, European Medicine Agency Reflection Paper on the Use of Macrolides, Lincosamides and Streptogramins (MLS) in Food-producing Animals in the European Union: Development of Resistance and Impact on Human and Animal Health 2011, EMA/CVMP/SAGAM/741087/2009 Committee for Medicinal Products for Veterinary Use (CVMP), http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2011/11/WC500118230.pdf (accessed November 2014).
131. EMA, European Medicine Agency Tylosin, Summary Report 2007, Committee for Veterinary Medicinal Products. EMEA/MRL/20597-FINAL, http://www.ema.europa.eu/docs/en_GB/document_library/Maximum_Residue_Limits_-_Report/2009/11/WC500015764.pdf (accessed November 2014).
132. Gutierrez I.R., Watanabe N., Harter T., Glaser B., Radke M. Effect of sulfonamide antibiotics on microbial diversity and activity in a Californian Mollic Haploxeralf. J. Soils Sedim. 2010, 10:537-544.
133. Watanabe N., Bergamaschi B.A., Loftin K.A., Meyer M.T., Harter T. Use and environmental occurrence of antibiotics in free stall dairy farms with manure forage fields. Environ. Sci. Technol. 2010, 44:6591-6600.
134. Liu F., Ying G.G., Tao R., Zhao J.L., Yang J.F., Zhao L.F. Effects of six selected antibiotics on plant growth and soil microbial and enzymatic activities. Environ. Pollut. 2009, 157:1636-1642.
135. Borghi A.A., Palma M.S.A. Tetracycline: production, waste treatment and environmental impact assessment. Braz. J. Pharm. Sci. 2014, 50:25-40.
136. Jeonga J., Songa W., Coopera W.J., Jungb J., Greaves J. Degradation of tetracycline antibiotics: mechanisms and kinetic studies for advanced oxidation/reduction processes. Chemosphere 2010, 5:533-540.
137. Sanderson H., Johnson D.J., Wilson C.J., Brain R.A., Solomon K.R. Probabilistic hazard assessment of environmentally occurring pharmaceuticals toxicity to fish, daphnids and algae by ECOSAR screening. Toxicol. Lett. 2003, 144:383-395.
138. Yazdankhah S.P., Scheie A.A., Høiby E.A., Lunestad B.T., Heir E., Fotland T.Ø., Naterstad K., Kruse H. Triclosan and antimicrobial resistance in bacteria: an overview. Microb. Drug Resist. 2006, 12:83-90.
139. Boxall A.B.A., Kolpin D.W., Halling-Sorensen B., Tolls J. Are veterinary medicines causing environmental risks?. Environ. Sci. Technol. 2003, 37:286-294.
140. Christen V., Hickmann S., Rechenberg B., Fent K. Highly active human pharmaceuticals in aquatic systems: a concept for their identification based on their mode of action. Aquat. Toxicol. 2010, 96:167-181.
141. Scientific Committee on Consumer Safety, SCCS Opinion on Triclosan, Antimicrobial Resistance 2010, http://ec.europa.eu/health/scientific_committees/consumer_safety/index_en.htm (accessed November 2014).
142. Russell A.D. Whither triclosan. J. Antimicrob. Chemother. 2004, 53:693-695.
143. Kim Y.M., Murugesan K., Schmidt S., Bokare V., Jeon J.R., Kim E.J., Chang Y.S. Triclosan susceptibility and co-metabolism - a comparison for three aerobic pollutant-degrading bacteria. Bioresour. Technol. 2011, 102:2206-2212.
144. Lolas I.B.Y., Chen X., Bester K., Nielsen J.L. Identification of triclosan-degrading bacteria using stable isotope probing, fluorescence in situ hybridization and microautoradiography. Microbiology 2012, 158:2796-2804.
145. Prosser R.S., Lissemore L., Topp E., Sibley P.K. Bioaccumulation of triclosan and triclocarban in plants grown in soils amended with municipal dewatered biosolids. Environ. Toxicol. Chem. 2014, 33:975-984.
146. Braoudaki M., Hilton A.C. Low level of cross-resistance between triclosan and antibiotics in Escherichia coli K-12 and E. coli O55 compared to E. coli O157. FEMS Microbiol. Lett. 2004, 235:305-309.
147. Miller T.R., Heidler J., Chillrud S.N., DeLaquil A., Ritchie J.C., Mihalic J.N., Bopp R., Halden R.U. Fate of triclosan and evidence for reductive dechlorination of triclocarban in estuarine sediments. Environ. Sci. Technol. 2008, 42:4570-4576.
148. Roh H., Subramanya N., Zhao F., Yu C.P., Sandt J., Chu K.H. Biodegradation potential of wastewater micropollutants by ammonia-oxidizing bacteria. Chemosphere 2009, 77:1084-1089.
149. Cha J., Cupples A.M. Triclocarban and triclosan biodegradation at field concentrations and the resulting leaching potentials in three agricultural soils. Chemosphere 2010, 81:494-499.
150. Meade M.J., Waddell R.L., Callahan T.M. Soil bacteria Pseudomonas putida and Alcaligenes xylosoxidans subsp. dentrificans inactivate triclosan in liquid and solid substrates. FEMS Microbiol. Lett. 2001, 204:45-48.
151. Lawrence J.R., Zhu B., Swerhone G.D.W., Roy J., Wassenaar L.I., Topp E., Korber D.R. Comparative microscale analysis of the effects of triclosan and triclocarban on the structure and function of river biofilm communities. Sci. Total Environ. 2009, 407:3307-3316.
152. Kookana R.S., Ali A., Smith L., Arshad M. Contrasting effects of two antimicrobial agents (triclosan and triclocarban) on biomineralisation of an organophosphate pesticide in soils. Chemosphere 2014, 107:360-365.
153. Waller N.J., Kookana R.S. Effect of triclosan on microbial activity in Australian soils. Environ. Toxicol. Chem. 2009, 28:65-70.